Anderson, C. S., Hackett, M. L. & House, A. O. (2004) Interventions for preventing depression after stroke. Cochrane Library, issue 3. Oxford: Update Software.
Arnett, P. A., Rao, S. M., Grafman, J.
et al (1997) Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding, and planning abilities. Neuropsychology, 11, 535–544.
Bergman, J. & Lerner, V. (2002) Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease. Clinical Neuropharmacology, 25, 107–110.
Blumer, D., Montouris, G. & Davies, K. (2004) The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy and Behavior, 5, 826–840.
Brown, R. J. & Trimble, M. R. (2000) Dissociative psychopathology, non-epileptic seizures and neurology. Journal of Neurology, Neurosurgery and Psychiatry, 69, 285–288.
Carskadon, M. A., Dement, W. C., Mitler, M. M.
et al (1986) Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep, 9, 519–524.
Carson, A. J., MacHale, S., Allen, K.
et al (2000) Depression after stroke and lesion location: a systematic review. Lancet, 356, 122–126.
Chemerinski, E. & Robinson, R. G. (2000) The neuropsychiatry of stroke. Psychosomatics, 41, 5–14.
Currier, M. G., Murray, G. B. & Welch, C. C. (1992) Electro-convulsive therapy for post stroke depressed geriatric patients. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 140–144.
David, A. S. & Prince, M. (2005) Psychosis following head injury: a critical review. Journal of Neurology, Neurosurgery and Psychiatry, 76 (suppl. 1), i53–60.
Ebrahim, I. O., Sharief, M. K., de Lacy, S.
et al (2003) Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. Journal of Neurology, Neurosurgery and Psychiatry, 74, 127–130.
Feinstein, A., du Boulay, G. & Ron, M. A. (1992) Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. British Journal of Psychiatry, 161, 680–685.
Feinstein, A., Roy, P., Lobaugh, N.
et al (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology, 62, 586–590.
Fiszman, A., Alves-Leon, S. V., Nunes, R. G.
et al (2004) Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy and Behavior, 5, 818–825.
Fleminger, S. (2003) Managing agitation and aggression after head injury. BMJ, 327, 4–5.
Fleminger, S., Oliver, D. & Greenwood, R. (2003a) Pharmacological management of agitation or aggression in people with acquired brain injury. Cochrane Library, issue 2. Oxford: Update Software.
Fleminger, S., Oliver, D., Lovestone, S.
et al (2003b) Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on. A partial replication. Journal of Neurology, Neurosurgery and Psychiatry, 74, 857–862.
Francis, P. & Baker, G. A. (1999) Non-epileptic attack disorder (NEAD): a comprehensive review. Seizure, 8, 53–61.
Ghazi-Noori, S., Chung, T. H., Deane, K. H. O.
et al (2004) Therapies for depression in Parkinson's disease Cochrane Library, issue 3. Oxford: Update Software.
Goldstein, L. H., Deale, A. C., Mitchell-O'Malley, S. J.
et al (2004) An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study. Cognitive and Behavioral Neurology, 17, 41–49.
Greene, Y. M., Tariot, P. N., Wishart, H.
et al (2000) A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. Journal of Clinical Psychopharmacology, 20, 350–356.
Gross, A., Devinsky, O., Westbrook, L. E.
et al (2000) Psychotropic medication use in patients with epilepsy: effect on seizure frequency. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 458–464.
Hawkes, N. D., Thomas, G. A., Jurewicz, A.
et al (2001) Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. Postgraduate Medical Journal, 77, 717–722.
Inouye, S. K., Bogardus, S. T., Charpentier, P. A.
et al (1999) A multicomponent intervention to prevent delirium in hospitalised older patients. New England Journal of Medicine, 340, 669–676.
Khan-Bourne, N. & Brown, R. G. (2003) Cognitive behaviour therapy for the treatment of depression in individuals with brain injury. Neuropsychological Rehabilitation, 13, 89–107.
Kneebone, I. I. & Dunmore, E. (2000) Psychological management of post-stroke depression. British Journal of Clinical Psychology, 39, 53–65.
Lincoln, N. B. & Flannaghan, T. (2003) Cognitive behavioural psychotherapy for depression following stroke: a randomized controlled trial. Stroke, 34, 111–115.
Mayou, R. & Bryant, B. (2002) Psychiatry of whiplash neck injury. British Journal of Psychiatry, 180, 441–448.
McKeith, I., Del Ser, T., Spano, P.
et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 356, 2031–2036.
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E.
et al (2001) Comparative outcomes for individual cognitive behaviour therapy, supportive expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 69, 942–949.
Narushima, K. & Robinson, R. G. (2003) The effect of early versus late antidepressant treatment on physical impairment associated with post-stroke depression: is there a time-related therapeutic window?
Journal of Nervous and Mental Disorders, 91, 645–652.
Narushima, K., Kosier, J. T. & Robinson, R. G. (2003) A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 423–430.
Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. New England Journal of Medicine, 340, 757–763.
Rascol, O., Goetz, C., Koller, W.
et al (2002) Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet, 359, 1589–1598.
Ring, H. A. & Serra-Mestres, J. (2002) Neuropsychiatry of the basal ganglia. Journal of Neurology, Neurosurgery and Psychiatry, 72, 12–21.
Schoenfeld, M., Myers, R. H. & Cupples, L. A. (1984) Increased rate of suicide among patients with Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry, 47, 1283–1287.
Schreurs, K. M., de Ridder, D. T. & Bensing, J. M. (2002) Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. Journal of Psychosomatic Research, 53, 775–781.
Schwartz, J. M. & Marsh, L. (2000) The psychiatric perspectives of epilepsy. Psychosomatics, 41, 31–38.
Siegert, R. J. & Abernethy, D. A. (2005) Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery and Psychiatry, 76, 469–475.
Simpson, G. & Tate, R. (2005) Clinical features of suicide attempts after traumatic brain injury. Journal of Nervous and Mental Disease, 193, 680–685.
Stenager, E. N., Stenager, E., Koch-Henricksen, N.
et al (1992) Suicide and multiple sclerosis: an epidemiological investigation. Journal of Neurology, Neurosurgery and Psychiatry, 55, 542–545.
Stenager, E. N., Madsen, C., Stenager, E.
et al (1998) Suicide in patients with stroke: epidemiological study. BMJ, 316, 1206.
Teasdale, T. W. & Engberg, A. W. (2001) Suicide after traumatic brain injury: a population study. Journal of Neurology, Neurosurgery and Psychiatry, 71, 436–440.
Tranel, D., Bechara, A. & Damasio, A. R. (2000) Decision making and the somatic marker hypothesis. In The New Cognitive Neurosciences (ed. Gazzaniga, M. S.) pp. 1047–1061. Cambridge, MA: MIT Press.
Turner-Stokes, L. & Hassan, N. (2002) Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives. Clinical Rehabilitation, 16, 248–260.
Vataja, R., Leppavuori, A., Pohjasvaara, T.
et al (2004) Poststroke depression and lesion location revisited. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 56–62.
Weigell-Weber, M., Scmid, W. & Spiegel, R. (1996) Psychiatric symptoms and CAG expansion in Huntington's disease. American Journal of Medical Genetics, 67, 53–57.
Witjes-Ané, M.N., Vegter-van der Vlis, M., van Vugt, J.
et al (2003) Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 7–16.